Mathias Hothum
Vermögen: 4 Mio $ am 31.05.2026
Vermögen: 4 Mio $ am 31.05.2026
Mathias Hothum is the founder of Hmm Consulting.
Current jobs include Deputy Chairman of the Supervisory Board at Heidelberg Pharma AG since 2020, Chairman of the Supervisory Board at GEUDER AG, Managing Director at dievini Hopp BioTech holding GmbH & Co. KG , Managing Director at dievini Verwaltungs GmbH, Co-Managing Director at TSG 1899 Hoffenheim Fußball-Besitzgesellschaft mbH & Co. KG, Non-Executive Director at Immatics NV since 2023, Managing Director at OH Venture Management GmbH, Member of the Supervisory Board at CureVac SE, Apogenix AG, Molecular Health GmbH, Novaliq GmbH, and CureVac NV since 2015.
Former jobs include Non-Executive Director at AC Immune SA, Director at Weinheim 216 GmbH & Co. KG, Director at Joimax GmbH, Co-Managing Director at Drug Delivery Systems Beteiligungs GmbH, and Member of the Supervisory Board at Molecular Health, Inc. Education includes undergraduate studies at the University of Mannheim and a doctorate from Otto-von-Guericke-Universität Magdeburg.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IMMATICS N.V. 0,25 % | 17.03.2026 | 329.521 ( 0,25 % ) | 4 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| HEIDELBERG PHARMA AG | Direktor/Vorstandsmitglied | 30.07.2015 |
| CUREVAC | Direktor/Vorstandsmitglied | 01.08.2015 |
| IMMATICS N.V. | Direktor/Vorstandsmitglied | 20.06.2023 |
GEUDER AG
GEUDER AG Medical SpecialtiesHealth Technology Manufactures ophthalmologic surgical instruments and devices | Vorsitzender | - |
Molecular Health GmbH
Molecular Health GmbH Packaged SoftwareTechnology Services Provides data-driven software technology solutions for transforming biomedical data into actionable insights | Direktor/Vorstandsmitglied | - |
Hmm Consulting | Vorstandsvorsitzender | - |
TSG 1899 Hoffenheim Fußball-Besitzgesellschaft mbH & Co. KG
TSG 1899 Hoffenheim Fußball-Besitzgesellschaft mbH & Co. KG Real Estate DevelopmentFinance Provides real estate services | Vorstandsvorsitzender | - |
dievini Verwaltungs GmbH | Vorstandsvorsitzender | - |
dievini Hopp BioTech holding GmbH & Co. KG
dievini Hopp BioTech holding GmbH & Co. KG Investment ManagersFinance dievini Hopp BioTech hldg invests in companies located in Germany. The firm focuses on the biotechnology sectors and industries. It provides financing for early stage capital requirements. | Vorstandsvorsitzender | - |
| ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░ | - |
| ░░░░░░░░ ░░░ ░░░░ ░░░░░ ░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░ ░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 20 |
|---|---|
AC Immune SA
AC Immune SA Pharmaceuticals: MajorHealth Technology Manufactures precision medicines for neurodegenerative diseases | Health Technology |
CureVac SE
CureVac SE BiotechnologyHealth Technology Develops tumor immunotherapies | Health Technology |
Heidelberg Pharma AG
Heidelberg Pharma AG Pharmaceuticals: MajorHealth Technology Develops cancer therapies | Health Technology |
University of Mannheim
University of Mannheim Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Apogenix AG
Apogenix AG BiotechnologyHealth Technology Develops immuno-oncology therapeutics for the treatment of cancer and malignant diseases | Health Technology |
Otto-von-Guericke-Universität Magdeburg
Otto-von-Guericke-Universität Magdeburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
dievini Hopp BioTech holding GmbH & Co. KG
dievini Hopp BioTech holding GmbH & Co. KG Investment ManagersFinance dievini Hopp BioTech hldg invests in companies located in Germany. The firm focuses on the biotechnology sectors and industries. It provides financing for early stage capital requirements. | Finance |
GEUDER AG
GEUDER AG Medical SpecialtiesHealth Technology Manufactures ophthalmologic surgical instruments and devices | Health Technology |
Weinheim 216 GmbH & Co. KG
Weinheim 216 GmbH & Co. KG BiotechnologyHealth Technology Engage in biological research | Health Technology |
Joimax GmbH
Joimax GmbH Medical SpecialtiesHealth Technology Develops and markets systems for endoscopic minimally invasive spinal surgery | Health Technology |
dievini Verwaltungs GmbH | |
Molecular Health GmbH
Molecular Health GmbH Packaged SoftwareTechnology Services Provides data-driven software technology solutions for transforming biomedical data into actionable insights | Technology Services |
Molecular Health, Inc.
Molecular Health, Inc. Packaged SoftwareTechnology Services Operates as a cloud-based healthcare decision support technology to enable evidence-based treatment decisions | Technology Services |
Novaliq GmbH
Novaliq GmbH Medical SpecialtiesHealth Technology Develops and markets drug delivery systems | Health Technology |
Drug Delivery Systems Beteiligungs GmbH
Drug Delivery Systems Beteiligungs GmbH Financial ConglomeratesFinance Provides investment services | Finance |
TSG 1899 Hoffenheim Fußball-Besitzgesellschaft mbH & Co. KG
TSG 1899 Hoffenheim Fußball-Besitzgesellschaft mbH & Co. KG Real Estate DevelopmentFinance Provides real estate services | Finance |
OH Venture Management GmbH
OH Venture Management GmbH Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Hmm Consulting | |
Immatics NV
Immatics NV Pharmaceuticals: MajorHealth Technology Engages in developing immunotherapies for cancer treatments | Health Technology |
CureVac NV
CureVac NV BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops medicines based on messenger ribonucleic acid which includes prophylactic vaccines, oncology, and molecular therapies | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen